BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26249760)

  • 1. Review of heart failure treatment in type 2 diabetes patients: It's at least as effective as in non-diabetic patients!
    Girerd N; Zannad F; Rossignol P
    Diabetes Metab; 2015 Dec; 41(6):446-55. PubMed ID: 26249760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of heart failure in patients with diabetes: clinical update.
    Bell DS
    Ethn Dis; 2002; 12(1):S1-12-8. PubMed ID: 11915848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
    Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
    Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction.
    Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V
    Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies.
    Carr AA; Kowey PR; Devereux RB; Brenner BM; Dahlöf B; Ibsen H; Lindholm LH; Lyle PA; Snapinn SM; Zhang Z; Edelman JM; Shahinfar S
    Am J Cardiol; 2005 Dec; 96(11):1530-6. PubMed ID: 16310435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis.
    Castagno D; Baird-Gunning J; Jhund PS; Biondi-Zoccai G; MacDonald MR; Petrie MC; Gaita F; McMurray JJ
    Am Heart J; 2011 Nov; 162(5):938-948.e2. PubMed ID: 22093212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis.
    Sun H; Guan Y; Wang L; Zhao Y; Lv H; Bi X; Wang H; Zhang X; Liu L; Wei M; Song H; Su G
    BMC Cardiovasc Disord; 2015 Mar; 15():25. PubMed ID: 25880202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes mellitus and chronic heart failure].
    Spinar J; Vítovec J
    Vnitr Lek; 2003 Dec; 49(12):927-34. PubMed ID: 15040157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender effect on the relation between diabetes and hospitalization for heart failure.
    Seghieri C; Francesconi P; Cipriani S; Rapanà M; Anichini R; Franconi F; Del Prato S; Seghieri G
    Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):51-5. PubMed ID: 21915814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Patients with Advanced Heart Failure Who Receive Device-Based Therapy for Primary Prevention of Sudden Cardiac Death: Insights from the Israeli ICD Registry.
    Suleiman M; Goldenberg I; Samniah N; Rosso R; Marai I; Pekar A; Khalameizer V; Militianu A; Glikson M
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):738-45. PubMed ID: 25754272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
    Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis.
    Bell DS; Lukas MA; Holdbrook FK; Fowler MB
    Curr Med Res Opin; 2006 Feb; 22(2):287-96. PubMed ID: 16466600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of beta-blockers for heart failure in patients with diabetes mellitus.
    Giles TD
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):32-7. PubMed ID: 19667606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.
    Smooke S; Horwich TB; Fonarow GC
    Am Heart J; 2005 Jan; 149(1):168-74. PubMed ID: 15660049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
    Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
    Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
    Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
    Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comorbidity in heart failure].
    Widmer F
    Ther Umsch; 2011 Feb; 68(2):103-6. PubMed ID: 21271541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.